| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |